Jared Kelly
Board Member
Oncolytics Biotech Inc (ONCY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jared Kelly
Jared Kelly is recorded as CEO and Board Member at Oncolytics Biotech Inc (ONCY). The proxy statement of Oncolytics Biotech Inc reports total compensation of $2,108,512 for Jared Kelly in fiscal 2025, including a base salary of $318,093.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Oncolytics Biotech Inc
Other people whose current roles at this company are on record from its filings.
- Kirk Look CFO
- John McAdory COO
- Allison Hagerman CTO
- Bernd R. Seizinger Board Member
- Deborah M. Brown Board Member
- James T. Parsons Board Member
- Jonathan Rigby Board Member
- Patricia S. Andrews Board Member
- Stephen Glover Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Oncolytics Biotech Inc (ONCY) | Chief Executive Officer | $318,093 | $2,108,512 |
Recent activity
No call appearances or filed executive changes recorded yet.